BON vs NATR vs UNFI vs USNA vs AMZN

For growth investors, Amazon.

com, Inc. (AMZN) is the stronger pick with 12. 4% revenue growth year-over-year, versus -21. 7% for Bon Natural Life Limited (BON). Nature's Sunshine Products, Inc. (NATR) offers the better valuation at 23. 2x trailing P/E (21. 8x forward), making it the more compelling value choice. Analysts rate Nature's Sunshine Products, Inc. (NATR) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Nature's Sunshine Products, Inc.

(NATR) is the cheapest at 23. 2x versus Amazon. com, Inc. at 37. 8x. On forward P/E, USANA Health Sciences, Inc. is actually cheaper at 10. 9x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Amazon.

com, Inc. (AMZN) delivered a total return of +64. 8%, compared to -99. 9% for Bon Natural Life Limited (BON). Over 10 years, the gap is even starker: AMZN returned +702. 2% versus BON's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Nature's Sunshine Products, Inc.

(NATR) is the lower-risk stock at 0. 59β versus Amazon. com, Inc. 's 1. 50β — meaning AMZN is approximately 157% more volatile than NATR relative to the S&P 500. On balance sheet safety, USANA Health Sciences, Inc. (USNA) carries a lower debt/equity ratio of 2% versus 2% for United Natural Foods, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Amazon.

com, Inc. (AMZN) is pulling ahead at 12. 4% versus -21. 7% for Bon Natural Life Limited (BON). On earnings-per-share growth, the picture is similar: Nature's Sunshine Products, Inc. grew EPS 165. 0% year-over-year, compared to -523. 5% for Bon Natural Life Limited. Over a 3-year CAGR, AMZN leads at 11. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Amazon.

com, Inc. (AMZN) is the more profitable company, earning 10. 8% net margin versus -10. 7% for Bon Natural Life Limited — meaning it keeps 10. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMZN leads at 11. 2% versus -8. 7% for BON. At the gross margin level — before operating expenses — USNA leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, USANA Health Sciences, Inc.

(USNA) trades at 10. 9x forward P/E versus 31. 4x for Amazon. com, Inc. — 20. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for USNA: 79. 9% to $35. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Nature's Sunshine Products, Inc.

(NATR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 59), +176. 8% 10Y return). Both have compounded well over 10 years (NATR: +176. 8%, USNA: -69. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (BON (Consumer Defensive) and NATR (Consumer Defensive) and UNFI (Consumer Defensive) and USNA (Consumer Defensive) and AMZN (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.